Dr. Scott Plotkin, MD
Claim this profileMassachusetts General Hospital
Studies Neurofibromatosis Syndrome
Studies Neurofibroma
6 reported clinical trials
15 drugs studied
Area of expertise
1Neurofibromatosis Syndrome
NF2 positive
LZTR1 positive
SMARCB1 positive
2Neurofibroma
NF2 positive
LZTR1 positive
SMARCB1 positive
Affiliated Hospitals
Clinical Trials Scott Plotkin, MD is currently running
Erenumab + Siltuximab
for Schwannomatosis Pain
This trial is testing two drugs, Siltuximab and Erenumab-Aooe, to see if they can help people with severe pain from schwannomatosis. Siltuximab blocks tumor growth signals, and Erenumab-Aooe blocks pain signals. The trial aims to find out if these drugs can make a difference for people whose pain is hard to treat. Erenumab has been shown to be safe and effective for chronic migraine treatment.
Recruiting0 awards Phase 22 criteria
REC-2282
for Meningioma
This trial is testing a new drug called REC-2282 to see if it can help treat specific brain tumors in patients who haven't responded to other treatments. The study will check if the drug can slow down or stop the growth of these tumors.
Recruiting0 awards Phase 2 & 35 criteria
More about Scott Plotkin, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Scott Plotkin, MD has experience with
- Erenumab-Aooe
- Siltuximab
- Letters About NF1 Care
- Brigatinib
- Neratinib
- Tanezumab
Breakdown of trials Scott Plotkin, MD has run
Neurofibromatosis Syndrome
Neurofibroma
Neurofibromatosis
Spinal Cord Neurofibroma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Plotkin, MD specialize in?
Scott Plotkin, MD focuses on Neurofibromatosis Syndrome and Neurofibroma. In particular, much of their work with Neurofibromatosis Syndrome has involved NF2 positive patients, or patients who are LZTR1 positive.
Is Scott Plotkin, MD currently recruiting for clinical trials?
Yes, Scott Plotkin, MD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Scott Plotkin, MD has studied deeply?
Yes, Scott Plotkin, MD has studied treatments such as Erenumab-Aooe, Siltuximab, Letters about NF1 Care.
What is the best way to schedule an appointment with Scott Plotkin, MD?
Apply for one of the trials that Scott Plotkin, MD is conducting.
What is the office address of Scott Plotkin, MD?
The office of Scott Plotkin, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.